The $850,000 price of a newly approved gene therapy for blindness stunned patient advocates, but the sticker shock could quickly wear off.



Comments

No comments yet. Be the first to comment!

MORE RESOURCES FROM SOURCE

More from Resources from Summit Global Education   technologyreview.com